Effects of angiotensin converting enzyme inhibition on endothelium-dependent vasodilatation in essential hypertensive patients - PubMed (original) (raw)
Effects of angiotensin converting enzyme inhibition on endothelium-dependent vasodilatation in essential hypertensive patients
S Taddei et al. J Hypertens. 1998 Apr.
Abstract
Background: Essential hypertension is characterized by an impairment of endothelium-dependent vasodilatation.
Objective: To test whether antihypertensive treatment with the angiotensin converting enzyme inhibitor lisinopril can improve vasodilatation in response to endothelium-dependent agonists in essential hypertensive patients.
Design and methods: We studied the effect of acute (6-8 h after dosing), prolonged (1 month) and chronic (12 months) lisinopril treatment on forearm blood flow response (strain-gauge plethysmography) induced in 10 hypertensive patients (aged 43.6 +/- 8.1 years, blood pressure 151.4 +/- 6.8/99.8 +/- 3.3 mmHg) by intrabrachial infusions of 0.15, 0.45, 1.5, 4.5, and 15 microg/100 ml per min acetylcholine and 5, 15, and 50 ng/100 ml per min bradykinin, two endothelium-dependent vasodilators, and 1, 2, and 4 microg/100 ml per min sodium nitroprusside, an endothelium-independent vasodilator. At baseline, vascular response was compared with that of 10 normotensive subjects (aged 42.4 +/- 6.6 years, blood pressure 118.4 +/- 6.1/77.8 +/- 3.4 mmHg).
Results: Hypertensive patients had blunted (P < 0.01 or less) vasodilatations in response to infusions of acetylcholine (from 3.7 +/- 0.3 to 18.3 +/- 4.9 ml/100 ml per min) and bradykinin (from 3.7 +/- 0.4 to 15.8 +/- 2.6 ml/100 ml per min) compared with those of controls (from 3.6 +/- 0.3 to 25.3 +/- 5.2 ml/100 ml per min for acetylcholine and from 3.7 +/- 0.3 to 26.9 +/- 4.9 ml/100 ml per min for bradykinin) whereas the responses to infusion of sodium nitroprusside were similar (from 3.6 +/- 0.3 to 18.5 +/- 3.9 and from 3.6 +/- 0.3 to 16.4 +/- 1.8 ml/100 ml per min, respectively). Acute and prolonged lisinopril treatments significantly (P < 0.05 or less) improved vasodilatation in response to infusion of bradykinin (from 3.7 +/- 0.4 to 24.5 +/- 4.9 and from 3.7 +/- 0.3 to 22.1 +/- 4.9 ml/100 ml per min, respectively), but not in response to infusions of acetylcholine and of sodium nitroprusside. Chronic lisinopril treatment increased (P < 0.05) the response to infusions of not only bradykinin (from 3.5 +/- 0.5 to 27.6 +/- 5.3 ml/100 ml per min), but also of acetylcholine (from 3.5 +/- 0.5 to 27.8 +/- 8.0 ml/100 ml per min) and sodium nitroprusside (from 3.4 +/- 0.6 to 25.9 +/- 8.5 ml/100 ml per min). However, when the responses to infusions of acetylcholine and bradykinin were normalized with respect to that to infusion of sodium nitroprusside, only the vasodilatation in response to infusion of bradykinin was shown to have been increased by lisinopril treatment.
Conclusions: Administration of lisinopril to patients with essential hypertension can selectively increase vasodilatation in response to infusion of bradykinin.
Similar articles
- Lacidipine restores endothelium-dependent vasodilation in essential hypertensive patients.
Taddei S, Virdis A, Ghiadoni L, Uleri S, Magagna A, Salvetti A. Taddei S, et al. Hypertension. 1997 Dec;30(6):1606-12. doi: 10.1161/01.hyp.30.6.1606. Hypertension. 1997. PMID: 9403590 - Effect of insulin on acetylcholine-induced vasodilation in normotensive subjects and patients with essential hypertension.
Taddei S, Virdis A, Mattei P, Natali A, Ferrannini E, Salvetti A. Taddei S, et al. Circulation. 1995 Nov 15;92(10):2911-8. doi: 10.1161/01.cir.92.10.2911. Circulation. 1995. PMID: 7586259 - Impaired endothelium-dependent vasodilation in patients with essential hypertension. Evidence that nitric oxide abnormality is not localized to a single signal transduction pathway.
Panza JA, García CE, Kilcoyne CM, Quyyumi AA, Cannon RO 3rd. Panza JA, et al. Circulation. 1995 Mar 15;91(6):1732-8. doi: 10.1161/01.cir.91.6.1732. Circulation. 1995. PMID: 7882481 Clinical Trial. - Pathogenetic factors in hypertension. Endothelial factors.
Taddei S, Salvetti A. Taddei S, et al. Clin Exp Hypertens. 1996 Apr-May;18(3-4):323-35. doi: 10.3109/10641969609088966. Clin Exp Hypertens. 1996. PMID: 8743024 Review. - Effect of angiotensin converting enzyme inhibitors on quality of life in hypertensive patients. Pharmacodynamic basis.
Govantes C, Marín J. Govantes C, et al. Fundam Clin Pharmacol. 1996;10(4):400-5. doi: 10.1111/j.1472-8206.1996.tb00592.x. Fundam Clin Pharmacol. 1996. PMID: 8871140 Review.
Cited by
- Inhibition of the renin angiotensin system: implications for the endothelium.
Savoia C, Schiffrin EL. Savoia C, et al. Curr Diab Rep. 2006 Aug;6(4):274-8. doi: 10.1007/s11892-006-0060-5. Curr Diab Rep. 2006. PMID: 16879778 Review. - Effectiveness of a multidrug therapy consisting of Ivermectin, Azithromycin, Montelukast, and Acetylsalicylic acid to prevent hospitalization and death among ambulatory COVID-19 cases in Tlaxcala, Mexico.
Lima-Morales R, Méndez-Hernández P, Flores YN, Osorno-Romero P, Sancho-Hernández CR, Cuecuecha-Rugerio E, Nava-Zamora A, Hernández-Galdamez DR, Romo-Dueñas DK, Salmerón J. Lima-Morales R, et al. Int J Infect Dis. 2021 Apr;105:598-605. doi: 10.1016/j.ijid.2021.02.014. Epub 2021 Feb 10. Int J Infect Dis. 2021. PMID: 33578014 Free PMC article. - Endothelial cell infection and endotheliitis in COVID-19.
Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, Mehra MR, Schuepbach RA, Ruschitzka F, Moch H. Varga Z, et al. Lancet. 2020 May 2;395(10234):1417-1418. doi: 10.1016/S0140-6736(20)30937-5. Epub 2020 Apr 21. Lancet. 2020. PMID: 32325026 Free PMC article. No abstract available. - Microvascular endothelial function and primary open angle glaucoma.
Mudassar Imran Bukhari S, Yew KK, Thambiraja R, Sulong S, Ghulam Rasool AH, Ahmad Tajudin LS. Mudassar Imran Bukhari S, et al. Ther Adv Ophthalmol. 2019 Aug 22;11:2515841419868100. doi: 10.1177/2515841419868100. eCollection 2019 Jan-Dec. Ther Adv Ophthalmol. 2019. PMID: 31489400 Free PMC article. - Systolic hypertension in the elderly: pushing the frontiers of therapy--a suggested new approach.
Stokes GS. Stokes GS. J Clin Hypertens (Greenwich). 2004 Apr;6(4):192-7. doi: 10.1111/j.1524-6175.2004.03508.x. J Clin Hypertens (Greenwich). 2004. PMID: 15073473 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical